Torréns et al. reported that vaccination with the E7 oncoprotein of human papillomavirus (HPV) type 16 and VSSP protects mice from tumor invasion, induces the established tumor regression, and produces an E7-specific CD8+ T cell response [58]. The gene discussed is CD8A; the disease is neoplasm.